Acetazolamide responsive episodic ataxia treated with methazolamide: a case report

Abstract

Acetazolamide-responsive ataxia is a rare episodic ataxia (EA) disorder characterized by paroxysmal cerebellar ataxia. Many of the symptoms with EA can be treated with the carbonic anhydrase inhibitor acetazolamide. EA is a family of channelopathies each with its own unique mutation. We report a case of EA treated with methlazolamide in a 37 year old man who experienced dysguesia with acetazolamide. Methazolamide has higher rates of diffusion into the tissue and a longer half-life compared with acetazolamide. It should be considered for episodic ataxia.

Published
Jan 12, 2015
How to Cite
LAKHAN, Shaheen E. Acetazolamide responsive episodic ataxia treated with methazolamide: a case report. International Archives of Medicine, [S.l.], v. 8, jan. 2015. ISSN 1755-7682. Available at: <http://imed.pub/ojs/index.php/iam/article/view/957>. Date accessed: 18 aug. 2018. doi: http://dx.doi.org/10.3823/1602.
Section
Neurology